Pharmacy teams highlight valproate risks

Latest

Pharmacy teams highlight valproate risks

In Latest

Community pharmacy teams play a significant role in raising awareness of the risks associated with valproate medicines and pregnancy, a practice audit has found.

Nearly 6,500 community pharmacies took part in the audit, which was organised by the cross-sector Community Pharmacy Patient Safety Group (CPPSG).

Among those who take valproate, up to four in ten babies are at risk of developmental disorders and approximately one in ten are at risk of birth defects. Despite increasing awareness, there were still 400 pregnancies in women taking valproate during 2016.

The audit, which took place in two stages between July and October 2018 and February and March 2019, found that:

  • Pharmacy teams’ awareness about the risks associated with valproate medicines and pregnancy improved over the audit period
  • There was an increase in the proportion of valproate prescriptions that indicated that a pregnancy prevention programme (PPP) was in place for the patient
  • One in five pharmacies indicated that they would appoint a ’valproate champion’ in their pharmacy.

CPPSG chair Janice Perkins said: “The audit’s findings demonstrate the significant role that pharmacy teams play in raising awareness and understanding about high-risk medicines among patients and their families and carers. Supporting women and girls prescribed valproate is a key priority across the whole health sector.”

Both phases of the audit were completed by around 6,500 community pharmacies, and during this time, over 36,000 valproate prescriptions were dispensed.

Ms Perkins added: “There are still improvements to be made. [We] will continue working to raise awareness and understanding among the profession to help eliminate avoidable harm caused by valproate.”

GPhC: more needs to be done

Duncan Rudkin, chief executive of the GPhC, acknowledged the positive findings but said there is still more to be done.

“I would urge every pharmacy owner and all pharmacists and pharmacy technicians to implement the recommendations made in the report. Pharmacies have a critical role to play in making sure that the PPP is followed every time [valproate is dispensed], so women and girls always receive the right information and support when they get their valproate prescription.

“Our inspectors are looking for evidence that pharmacy teams are complying with the PPP for valproate in every inspection. Any pharmacy found not to be complying would have to take immediate action to resolve this.”

Photo credit: Mark Thomas/Science Photo Library

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

NHS text message urges millions to get Covid jab

The NHS is sending millions of vulnerable people text messages urging them to get the Covid-19 vaccination.

1 Min Article

bookmark_icon_off
Latest

RoE Awards: New Covid-19 category launched

In light of the inspirational stories emerging during the Covid-19 pandemic, a new RoE Awards category has been launched.

1 Min Article

bookmark_icon_off
Latest

Boots creates 30k ‘quiet shopping slots’ for key workers

Boots customers who wish to pick up their items when the store is less busy are now able to book ‘quiet shopping slots,’ the multiple has said.

1 Min Article

bookmark_icon_off
Latest

GPhC survey aims to improve the way it regulates

A GPhC survey is seeking views of pharmacists and technicians on their roles, responsibilities and job satisfaction.

1 Min Article

bookmark_icon_off
Latest

PDA defends right of locums to set their rates

PDA warns off companies which threaten to report locums who raise rates to GPhC.

1 Min Article

bookmark_icon_off
Latest

Dukes to leave PSNC in September

PSNC chief executive Simon Dukes will leave his post at the end of September after just over three and-a-half years in the role.

1 Min Article

Recommended Learning

bookmark_icon_off
Sponsored modules

OTC Omeprazole tablets 20mg: an opportunity for pharmacy

This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.

10 Min Module

bookmark_icon_off
Sponsored modules

Relief from the nasal symptoms of allergy

With NHS England advising that OTC products should no longer be prescribed to treat mild-to-moderate hayfever, pharmacy’s role in supporting sufferers is more important than ever. This module includes self-care advice and product recommendations to aid customer conversations.

900 Min Module

bookmark_icon_off
Sponsored modules

Constipation: Making effective recommendations

Learn how to help customers with constipation and find out how even brief conversations can have a positive influence on their health. 

15 Min Module

bookmark_icon_off
Sponsored modules

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

21 Min Module

Sponsored modules

Treating fungal nail infections

Understand how fungal nail infections develop and help manage customer expectations around treatment

3 Min Module

bookmark_icon_off
Sponsored modules

This module will help the pharmacy team to understand erectile dysfunction and its causes, and supply Viagra Connect to male customers affected by it, where appropriate

10 Min Module